|
1
|
Seguin L, Durandy M and Feral CC: Lung
adenocarcinoma tumor origin: A guide for personalized medicine.
Cancers (Basel). 14:17592022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen Z, Fillmore CM, Hammerman PS, Kim CF
and Wong KK: Non-small-cell lung cancers: A heterogeneous set of
diseases. Nat Rev Cancer. 14:535–546. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Davidson MR, Gazdar AF and Clarke BE: The
pivotal role of pathology in the management of lung cancer. J
Thorac Dis. 5 (Suppl 5):S463–S478. 2013.PubMed/NCBI
|
|
4
|
Zito Marino F, Bianco R, Accardo M, Ronchi
A, Cozzolino I, Morgillo F, Rossi G and Franco R: Molecular
heterogeneity in lung cancer: From mechanisms of origin to clinical
implications. Int J Med Sci. 16:981–989. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Langer CJ, Besse B, Gualberto A, Brambilla
E and Soria JC: The evolving role of histology in the management of
advanced non-small-cell lung cancer. J Clin Oncol. 28:5311–5320.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Iqbal MA, Arora S, Prakasam G, Calin GA
and Syed MA: MicroRNA in lung cancer: Role, mechanisms, pathways
and therapeutic relevance. Mol Aspects Med. 70:3–20. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ishola AA, La'ah AS, Le HD, Nguyen VQ,
Yang YP, Chou SJ, Tai HY, Chien CS and Wang ML: Non-coding RNA and
lung cancer progression. J Chin Med. 83:8–14. 2020.
|
|
8
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Landi MT, Zhao Y, Rotunno M, Koshiol J,
Liu H, Bergen AW, Rubagotti M, Goldstein AM, Linnoila I, Marincola
FM, et al: MicroRNA expression differentiates histology and
predicts survival of lung cancer. Clin Cancer Res. 16:430–441.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang X, Xie K, Zhou H, Wu Y, Li C, Liu Y,
Liu Z, Xu Q, Liu S, Xiao D and Tao Y: Role of non-coding RNAs and
RNA modifiers in cancer therapy resistance. Mol Cancer. 19:472020.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hanna J, Hossain GS and Kocerha J: The
potential for microRNA therapeutics and clinical research. Front
Genet. 10:4782019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li G, Fang J, Wang Y, Wang H and Sun CC:
MiRNA-based therapeutic strategy in lung cancer. Curr Pharm Des.
23:6011–6018. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Agrawal N, Dasaradhi PVN, Mohmmed A,
Malhotra P, Bhatnagar RK and Mukherjee SK: RNA interference:
Biology, mechanism, and applications. Microbiol Mol Biol Rev.
67:657–685. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Michlewski G and Cáceres JF:
Post-transcriptional control of miRNA biogenesis. RNA. 25:1–16.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guo WT and Wang Y: Dgcr8 knockout
approaches to understand microRNA functions in vitro and in vivo.
Cell Mol Life Sci. 76:1697–1711. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu TX and Rothenberg ME: MicroRNA. J
Allergy Clin Immunol. 141:1202–1217. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Heyam A, Lagos D and Plevin M: Dissecting
the roles of TRBP and PACT in double-stranded RNA recognition and
processing of noncoding RNAs. Wiley Interdiscip Rev RNA. 6:271–289.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Linder P and Jankowsky E: From unwinding
to clamping-the DEAD box RNA helicase family. Nat Rev Mol Cell
Biol. 12:505–616. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Williams AE: Functional aspects of animal
microRNAs. Cell Mol Life Sci. 65:545–562. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Du T and Zamore PD: microPrimer: The
biogenesis and function of microRNA. Development. 132:4645–4652.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Treiber T, Treiber N and Meister G:
Regulation of microRNA biogenesis and function. Thromb Haemost.
107:605–610. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ren H and Wang Q: Non-coding RNA and
diabetic kidney disease. DNA Cell Biol. 40:553–567. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gizak A, Duda P, Pielka E, McCubrey JA and
Rakus D: GSK3 and miRNA in neural tissue: From brain development to
neurodegenerative diseases. Biochim Biophys Acta Mol Cell Res.
1867:1186962020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hill M and Tran N: miRNA interplay:
Mechanisms and consequences in cancer. Dis Model Mech.
14:dmm0476622021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee YS and Dutta A: MicroRNAs in cancer.
Annu Rev Pathol. 4:199–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Long H, Wang Z, Chen J, Xiang T, Li Q,
Diao X and Zhu B: microRNA-214 promotes epithelial-mesenchymal
transition and metastasis in lung adenocarcinoma by targeting the
suppressor-of-fused protein (Sufu). Oncotarget. 6:38705–38718.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Han L, Huang Z, Liu Y, Ye L, Li D, Yao Z,
Wang C, Zhang Y, Yang H, Tan Z, et al: MicroRNA-106a regulates
autophagy-related cell death and EMT by targeting TP53INP1 in lung
cancer with bone metastasis. Cell Death Dis. 12:10372021.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Luo J, Xia L, Zhang L, Zhao K and Li C:
MiRNA-144-5p down-modulates CDCA3 to regulate proliferation and
apoptosis of lung adenocarcinoma cells. Mutat Res. 825:1117982022.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mo D, Yang D, Xiao X, Sun R, Huang L and
Xu J: MiRNA-145 suppresses lung adenocarcinoma cell invasion and
migration by targeting N-cadherin. Biotechnol Lett. 39:701–710.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yin R, Zhang S, Wu Y, Fan X, Jiang F,
Zhang Z, Feng D, Guo X and Xu L: microRNA-145 suppresses lung
adenocarcinoma-initiating cell proliferation by targeting OCT4.
Oncol Rep. 25:1747–1754. 2011.PubMed/NCBI
|
|
31
|
Zhang JX, Yang W, Wu JZ, Zhou C, Liu S,
Shi HB and Zhou WZ: MicroRNA-32-5p inhibits epithelial-mesenchymal
transition and metastasis in lung adenocarcinoma by targeting SMAD
family 3. J Cancer. 12:2258–2267. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu J, Si L and Tian H: MicroRNA-148a
inhibits cell proliferation and cell cycle progression in lung
adenocarcinoma via directly targeting transcription factor E2F3.
Exp Ther Med. 16:5400–5409. 2018.PubMed/NCBI
|
|
33
|
Lu Y, Zheng W, Rao X, Du Y and Xue J:
MicroRNA-9-5p facilitates lung adenocarcinoma cell malignant
progression via targeting STARD13. Biochem Genet. 60:1865–1880.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhu K, Lin J, Chen S and Xu Q: miR-9-5p
promotes lung adenocarcinoma cell proliferation, migration and
invasion by targeting ID4. Technol Cancer Res Treat.
20:153303382110485922021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Han HS, Son SM, Yun J, Jo YN and Lee OJ:
MicroRNA-29a suppresses the growth, migration, and invasion of lung
adenocarcinoma cells by targeting carcinoembryonic antigen-related
cell adhesion molecule 6. FEBS Lett. 588:3744–3750. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cao J, He Y, Liu HQ, Wang SB, Zhao BC and
Cheng YS: MicroRNA 192 regulates chemo-resistance of lung
adenocarcinoma for gemcitabine and cisplatin combined therapy by
targeting Bcl-2. Int J Clin Exp Med. 8:12397–12403. 2015.PubMed/NCBI
|
|
37
|
Ma Z, Chen G, Chen Y, Guo Z, Chai H, Tang
Y, Zheng L, Wei K, Pan C, Ma Z, et al: MiR-937-3p promotes
metastasis and angiogenesis and is activated by MYC in lung
adenocarcinoma. Cancer Cell Int. 22:312022. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Duan L, Wang J, Zhang D, Yuan Y, Tang L,
Zhou Y and Jiang X: Immune-related miRNA-195-5p inhibits the
progression of lung adenocarcinoma by targeting polypyrimidine
tract-binding protein 1. Front Oncol. 12:8625642022. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bu L, Tian Y, Wen H, Jia W and Yang S:
miR-195-5p exerts tumor-suppressive functions in human lung cancer
cells through targeting TrxR2. Acta Biochim Biophys Sin (Shanghai).
53:189–200. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yuan C, Bai R, Gao Y, Jiang X, Li S, Sun
W, Li Y, Huang Z, Gong Y and Xie C: Effects of MicroRNA-195-5p on
biological behaviors and radiosensitivity of lung adenocarcinoma
cells via targeting HOXA10. Oxid Med Cell Longev. 2021:45222102021.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cao X, Xue F, Chen H, Shen L, Yuan X, Yu
Y, Zong Y, Zhong L and Huang F: MiR-202-3p inhibits the
proliferation and metastasis of lung adenocarcinoma cells by
targeting RRM2. Ann Transl Med. 10:13742022. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhuang L, Shou T, Li K, Gao CL, Duan LC,
Fang LZ, Zhang QY, Chen ZN, Zhang C, Yang ST and Li GF:
MicroRNA-30e-5p promotes cell growth by targeting PTPN13 and
indicates poor survival and recurrence in lung adenocarcinoma. J
Cell Mol Med. 21:2852–2862. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhao S, Gao X, Zang S, Li Y, Feng X and
Yuan X: MicroRNA-383-5p acts as a prognostic marker and inhibitor
of cell proliferation in lung adenocarcinoma by cancerous inhibitor
of protein phosphatase 2A. Oncol Lett. 14:3573–3579. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sato T, Shiba-Ishii A, Kim Y, Dai T, Husni
RE, Hong J, Kano J, Sakashita S, Iijima T and Noguchi M: miR-3941:
A novel microRNA that controls IGBP1 expression and is associated
with malignant progression of lung adenocarcinoma. Cancer Sci.
108:536–542. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Pu X, Jiang H, Li W, Xu L, Wang L and Shu
Y: Upregulation of the coatomer protein complex subunit beta 2
(COPB2) gene targets microRNA-335-3p in NCI-H1975 lung
adenocarcinoma cells to promote cell proliferation and migration.
Med Sci Monit. 26:e9183822020. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hu WB, Wang L, Huang XR and Li F:
MicroRNA-204 targets SOX4 to inhibit metastasis of lung
adenocarcinoma. Eur Rev Med Pharmacol Sci. 23:1553–1562.
2019.PubMed/NCBI
|
|
47
|
Zhou Y, Zhao M, Du Y, Liu Y, Zhao G, Ye L,
Li Q, Li H, Wang X, Liu X, et al: MicroRNA-195 suppresses the
progression of lung adenocarcinoma by directly targeting apelin.
Thorac Cancer. 10:1419–1430. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wu X, Wu G, Zhang H, Peng X, Huang B,
Huang M, Ding J, Mao C and Peng C: MiR-196b promotes the invasion
and migration of lung adenocarcinoma cells by targeting AQP4.
Technol Cancer Res Treat. 20:15330338209858682021. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Pan L, Tang Z, Pan L and Tang R:
MicroRNA-3666 inhibits lung cancer cell proliferation, migration,
and invasiveness by targeting BPTF. Biochem Cell Biol. 97:415–422.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Mou X and Liu S: MiR-485 inhibits
metastasis and EMT of lung adenocarcinoma by targeting Flot2.
Biochem Biophys Res Commun. 477:521–526. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Li J, Chen Y, Jin M, Wang J, Li S, Chen Z
and Yu W: MicroRNA-134 reverses multidrug resistance in human lung
adenocarcinoma cells by targeting FOXM1. Oncol Lett. 13:1451–1455.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Gao Y, Xue Q, Wang D, Du M, Zhang Y and
Gao S: miR-873 induces lung adenocarcinoma cell proliferation and
migration by targeting SRCIN1. Am J Transl Res. 7:2519–2526.
2015.PubMed/NCBI
|
|
53
|
Liu L, Bi N, Wu L, Ding X, Men Y, Zhou W,
Li L, Zhang W, Shi S, Song Y and Wang L: MicroRNA-29c functions as
a tumor suppressor by targeting VEGFA in lung adenocarcinoma. Mol
Cancer. 16:502017. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Chai Y, Xue H, Wu Y, Du X, Zhang Z, Zhang
Y, Zhang L, Zhang S, Zhang Z and Xue Z: MicroRNA-216b-3p inhibits
lung adenocarcinoma cell growth via regulating PDZ binding
kinase/T-LAK-cell-originated protein kinase. Exp Ther Med.
15:4822–4828. 2018.PubMed/NCBI
|
|
55
|
Zhu D, Gu L, Li Z, Jin W, Lu Q and Ren T:
MiR-138-5p suppresses lung adenocarcinoma cell
epithelial-mesenchymal transition, proliferation and metastasis by
targeting ZEB2. Pathol Res Pract. 215:861–872. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Liu Y, Wang F and Xu P: miR-590
accelerates lung adenocarcinoma migration and invasion through
directly suppressing functional target OLFM4. Biomed Pharmacother.
86:466–474. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wang M, Wang Y, Zang W, Wang H, Chu H, Li
P, Li M, Zhang G and Zhao G: Downregulation of microRNA-182
inhibits cell growth and invasion by targeting programmed cell
death 4 in human lung adenocarcinoma cells. Tumour Biol. 35:39–46.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Greenawalt EJ, Edmonds MD, Jain N, Adams
CM, Mitra R and Eischen CM: Targeting of SGK1 by miR-576-3p
inhibits lung adenocarcinoma migration and invasion. Mol Cancer
Res. 17:289–298. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Li X, Fu Q, Li H, Zhu L, Chen W, Ruan T,
Xu W and Yu X: MicroRNA-520c-3p functions as a novel tumor
suppressor in lung adenocarcinoma. FEBS J. 286:2737–2752. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Fan G, Xu P and Tu P: MiR-1827 functions
as a tumor suppressor in lung adenocarcinoma by targeting MYC and
FAM83F. J Cell Biochem. 121:1675–1689. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wu A, Yang X, Zhang B, Wang S and Li G:
miR-516a-3p promotes proliferation, migration, and invasion and
inhibits apoptosis in lung adenocarcinoma by targeting PTPRD. Int J
Clin Exp Pathol. 12:4222–4231. 2019.PubMed/NCBI
|
|
62
|
Qin E, Gu S, Guo Y, Wang L and Pu G:
MiRNA-30a-5p/VCAN arrests tumor metastasis via modulating the
adhesion of lung adenocarcinoma cells. Appl Biochem Biotechnol. Apr
10–2023.(Epub ahead of print). View Article : Google Scholar
|
|
63
|
Tao K, Liu J, Liang J, Xu X, Xu L and Mao
W: Vascular endothelial cell-derived exosomal miR-30a-5p inhibits
lung adenocarcinoma malignant progression by targeting CCNE2.
Carcinogenesis. 42:1056–1067. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Zhang G, Wu YJ and Yan F: MicroRNA-130-5p
promotes invasion as well as migration of lung adenocarcinoma cells
by targeting the EZH2 signaling pathway. Eur Rev Med Pharmacol Sci.
23:9480–9488. 2019.PubMed/NCBI
|
|
65
|
Dai B, Kong DL, Tian J, Liu TW, Zhou H and
Wang ZF: microRNA-1205 promotes cell growth by targeting APC2 in
lung adenocarcinoma. Eur Rev Med Pharmacol Sci. 23:1125–1133.
2019.PubMed/NCBI
|
|
66
|
Bai J, Hu Y, Chen X, Chen L, Zhang L, Yin
C and Li H: miR-144-3p inhibits the invasion and metastasis of lung
adenocarcinoma cells by targeting IRS1. Zhongguo Fei Ai Za Zhi.
24:323–330. 2021.(In Chinese). PubMed/NCBI
|
|
67
|
Liu K, Zhang W, Tan J, Ma J and Zhao J:
MiR-200b-3p functions as an oncogene by targeting ABCA1 in lung
adenocarcinoma. Technol Cancer Res Treat. 18:15330338198925902019.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Guo ZZ, Ma ZJ, He YZ, Jiang W, Xia Y, Pan
CF, Wei K, Shi YJ, Chen L and Chen YJ: miR-550a-5p functions as a
tumor promoter by targeting LIMD1 in lung adenocarcinoma. Front
Oncol. 10:5707332020. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Sun Y, Zhao J, Yin X, Yuan X, Guo J and Bi
J: miR-297 acts as an oncogene by targeting GPC5 in lung
adenocarcinoma. Cell Prolif. 49:636–643. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Chen Y and Yang C: miR-197-3p-induced
downregulation of lysine 63 deubiquitinase promotes cell
proliferation and inhibits cell apoptosis in lung adenocarcinoma
cell lines. Mol Med Rep. 17:3921–3927. 2018.PubMed/NCBI
|
|
71
|
Fang H, Liu Y, He Y, Jiang Y, Wei Y, Liu
H, Gong Y and An G: Extracellular vesicle-delivered miR-505-5p, as
a diagnostic biomarker of early lung adenocarcinoma, inhibits cell
apoptosis by targeting TP53AIP1. Int J Oncol. 54:1821–1832.
2019.PubMed/NCBI
|
|
72
|
Qian T, Shi S, Xie L and Zhu Y: miR-938
promotes cell proliferation by regulating RBM5 in lung
adenocarcinoma cells. Cell Biol Int. 44:295–305. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Cao J, Geng J, Chu X, Wang R, Huang G and
Chen L: miRNA-885-3p inhibits docetaxel chemoresistance in lung
adenocarcinoma by downregulating Aurora A. Oncol Rep. 41:1218–1230.
2019.PubMed/NCBI
|
|
74
|
Bao B, Yu X and Zheng W: MiR-139-5p
targeting CCNB1 modulates proliferation, migration, invasion and
cell cycle in lung adenocarcinoma. Mol Biotechnol. 64:852–860.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Li J, He X, Wu X, Liu X, Huang Y and Gong
Y: miR-139-5p inhibits lung adenocarcinoma cell proliferation,
migration, and invasion by targeting MAD2L1. Comput Math Methods
Med. 2020:29535982020. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Wang Z, Zhou L, Chen B, Li X, Zou Q, Xu W,
Fang L, Wu A, Li Z and Chen Y: microRNA-660 enhances cisplatin
sensitivity via decreasing SATB2 expression in lung adenocarcinoma.
Genes. 14:9112023. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Feng YY, Liu CH, Xue Y, Chen YY, Wang YL
and Wu XZ: MicroRNA-147b promotes lung adenocarcinoma cell
aggressiveness through negatively regulating microfibril-associated
glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma
patients. Gene. 730:1443162020. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Wan S, Liu Z, Chen Y, Mai Z, Jiang M, Di Q
and Sun B: MicroRNA-140-3p represses the proliferation, migration,
invasion and angiogenesis of lung adenocarcinoma cells via
targeting TYMS (thymidylate synthetase). Bioengineered.
12:11959–11977. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Wang H, Kanmangne D, Li R, Qian Z, Xia X,
Wang X and Wang T: miR-30a-3p suppresses the proliferation and
migration of lung adenocarcinoma cells by downregulating CNPY2.
Oncol Rep. 43:646–654. 2020.PubMed/NCBI
|
|
80
|
Chen L, Chen X, Liu L, Zhao Y, Zuo W, Yin
C and Li H: miR-30b-3p inhibits the proliferation and invasion of
lung adenocarcinoma by targeting COX6B1. Zhongguo Fei Ai Za Zhi.
25:567–574. 2022.(In Chinese). PubMed/NCBI
|
|
81
|
Tu Y and Mei F: miR-3648 promotes lung
adenocarcinoma-genesis by inhibiting SOCS2 (suppressor of cytokine
signaling 2). Bioengineered. 13:3044–3056. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Liu Z, Cui Y, Wang S, Wu C, Mei F, Han E,
Hu Z and Zhou B: MiR-96-5p is an oncogene in lung adenocarcinoma
and facilitates tumor progression through ARHGAP6 downregulation. J
Appl Genet. 62:631–638. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Zhou F, Qian C, Chen T and Zang X:
MiR-96-5p facilitates lung adenocarcinoma cell phenotypes by
inhibiting FHL1. Comput Math Methods Med. 2022:78912222022.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Chen G, Wang Q and Wang K: MicroRNA-218-5p
affects lung adenocarcinoma progression through targeting
endoplasmic reticulum oxidoreductase 1 alpha. Bioengineered.
13:10061–10070. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Miao H, Zeng Q, Xu S and Chen Z:
miR-1-3p/CELSR3 participates in regulating malignant phenotypes of
lung adenocarcinoma cells. Curr Gene Ther. 21:304–312. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Li T, Wang X, Jing L and Li Y: MiR-1-3p
inhibits lung adenocarcinoma cell tumorigenesis via targeting
protein regulator of cytokinesis 1. Front Oncol. 9:1202019.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
An JC, Shi HB, Hao WB, Zhu K and Ma B:
miR-944 inhibits lung adenocarcinoma tumorigenesis by targeting
STAT1 interaction. Oncol Lett. 17:3790–3798. 2019.PubMed/NCBI
|
|
88
|
Feng H, Zhang Z, Qing X, French SW and Liu
D: miR-186-5p promotes cell growth, migration and invasion of lung
adenocarcinoma by targeting PTEN. Exp Mol Pathol. 108:105–113.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Xu Q and Xu Z: miR-196b-5p promotes
proliferation, migration and invasion of lung adenocarcinoma cells
via targeting RSPO2. Cancer Manag Res. 12:13393–13402. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Lin R, Li GS, Gan XY, Peng JX, Feng Y,
Wang LT, Zhang CY, Huang KY, Huang SH, Yang L, et al: The clinical
significance and mechanism of microRNA-22-3p targeting TP53 in lung
adenocarcinoma. Technol Health Care. 31:1691–1707. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Goto A, Tanaka M, Yoshida M, Umakoshi M,
Nanjo H, Shiraishi K, Saito M, Kohno T, Kuriyama S, Konno H, et al:
The low expression of miR-451 predicts a worse prognosis in
non-small cell lung cancer cases. PLoS One. 12:e01812702017.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Wang G, Zhou Y, Chen W, Yang Y, Ye J, Ou H
and Wu H: miR-21-5p promotes lung adenocarcinoma cell
proliferation, migration and invasion via targeting WWC2. Cancer
Biomark. 28:549–559. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Wei D: MiR-486-5p specifically suppresses
SAPCD2 expression, which attenuates the aggressive phenotypes of
lung adenocarcinoma cells. Histol Histopathol. 37:909–917.
2022.PubMed/NCBI
|
|
94
|
Yang W, Bai J, Liu D, Wang S, Zhao N, Che
R and Zhang H: MiR-93-5p up-regulation is involved in non-small
cell lung cancer cells proliferation and migration and poor
prognosis. Gene. 647:13–20. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Shao L, He Q, Wang J, He F, Lin S, Wu L,
Gao Y, Ma W, Dong J, Yang X and Li F: MicroRNA-326 attenuates
immune escape and prevents metastasis in lung adenocarcinoma by
targeting PD-L1 and B7-H3. Cell Death Discov. 7:1452021. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Zhao J, Yu H, Han T and Zhu X: Prognosis
value of microRNA-3677-3p in lung adenocarcinoma and its regulatory
effect on tumor progression. Cancer Manag Res. 13:9261–9270. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Ling DJ, Chen ZS, Zhang YD, Liao QD, Feng
JX, Zhang XY and Shi TS: MicroRNA-145 inhibits lung cancer cell
metastasis. Mol Med Rep. 11:3108–3114. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Zhang HB, Shen B, Ma ZC, Xu YY, Lou YL and
Chen M: MiR-593-5p inhibited proliferation and migration of lung
adenocarcinoma by targeting ICAM-1. Eur Rev Med Pharmacol Sci.
24:4298–4305. 2020.PubMed/NCBI
|
|
99
|
Huang JY, Cui SY, Chen YT, Song HZ, Huang
GC, Feng B, Sun M, De W, Wang R and Chen LB: MicroRNA-650 was a
prognostic factor in human lung adenocarcinoma and confers the
docetaxel chemoresistance of lung adenocarcinoma cells via
regulating Bcl-2/Bax expression. PLoS One. 8:e726152013. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Zhuo E, Cai C, Liu W, Li K and Zhao W:
Downregulated microRNA-140-5p expression regulates apoptosis,
migration and invasion of lung cancer cells by targeting zinc
finger protein 800. Oncol Lett. 20:3902020. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Wang X, Xiao H, Wu D, Zhang D and Zhang Z:
miR-335-5p regulates cell cycle and metastasis in lung
adenocarcinoma by targeting CCNB2. Onco Targets Ther. 13:6255–6263.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Chen L, Heikkinen L, Wang C, Yang Y, Sun H
and Wong G: Trends in the development of miRNA bioinformatics
tools. Brief Bioinform. 20:1836–1852. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Petkova V, Marinova D, Kyurkchiyan S,
Stancheva G, Mekov E, Kachakova-Yordanova D, Slavova Y, Kostadinov
D, Mitev V and Kaneva R: MiRNA expression profiling in
adenocarcinoma and squamous cell lung carcinoma reveals both common
and specific deregulated microRNAs. Medicine (Baltimore).
101:e300272022. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Jin X, Chen Y, Chen H, Fei S, Chen D, Cai
X, Liu L, Lin B, Su H, Zhao L, et al: Evaluation of tumor-derived
exosomal miRNA as potential diagnostic biomarkers for early-stage
non-small cell lung cancer using next-generation sequencing. Clin
Cancer Res. 23:5311–5319. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Sun Z, Shi K, Yang S, Liu J, Zhou Q, Wang
G, Song J, Li Z, Zhang Z and Yuan W: Effect of exosomal miRNA on
cancer biology and clinical applications. Mol Cancer. 17:1472018.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Rupaimoole R and Slack FJ: MicroRNA
therapeutics: Towards a new era for the management of cancer and
other diseases. Nat Rev Drug Discov. 16:203–222. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Saliminejad K, Khorram Khorshid HR,
Soleymani Fard S and Ghaffari SH: An overview of microRNAs:
Biology, functions, therapeutics, and analysis methods. J Cell
Physiol. 234:5451–5465. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Seijo LM, Peled N, Ajona D, Boeri M, Field
JK, Sozzi G, Pio R, Zulueta JJ, Spira A, Massion PP, et al:
Biomarkers in lung cancer screening: Achievements, promises, and
challenges. J Thorac Oncol. 14:343–357. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Kim Y, Sim J, Kim H, Bang SS, Jee S, Park
S and Jang K: MicroRNA-374a expression as a prognostic biomarker in
lung adenocarcinoma. J Pathol Transl Med. 53:354–360. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Tong L, Han WZ, Wang JL, Sun NN and Zhuang
M: MicroRNA-365 inhibits the progression of lung adenocarcinoma
through targeting ETS1 and inactivating AKT/mTOR pathway. Eur Rev
Med Pharmacol Sci. 24:4836–4845. 2020.PubMed/NCBI
|
|
112
|
Kim Y, Kim H, Bang S, Jee S and Jang K:
MicroRNA-130b functions as an oncogene and is a predictive marker
of poor prognosis in lung adenocarcinoma. Lab Invest. 101:155–164.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Sun Y, Mei H, Xu C, Tang H and Wei W:
Circulating microRNA-339-5p and −21 in plasma as an early detection
predictors of lung adenocarcinoma. Pathol Res Pract. 214:119–125.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Evan GI and Vousden KH: Proliferation,
cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Li X and Wu X: MiR-21-5p promotes the
progression of non-small-cell lung cancer by regulating the
expression of SMAD7. Onco Targets Ther. 11:8445–8454. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Chen J, Li X, Yang L and Zhang J: Long
non-coding RNA LINC01969 promotes ovarian cancer by regulating the
miR-144-5p/LARP1 axis as a competing endogenous RNA. Front Cell Dev
Biol. 8:6257302021. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Perlikos F, Harrington KJ and Syrigos KN:
Key molecular mechanisms in lung cancer invasion and metastasis: A
comprehensive review. Crit Rev Oncol Hematol. 87:1–11. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Verma V and Lautenschlaeger T: MicroRNAs
in non-small cell lung cancer invasion and metastasis: From the
perspective of the radiation oncologist. Expert Rev Anticancer
Ther. 16:767–774. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Pastushenko I and Blanpain C: EMT
transition states during tumor progression and metastasis. Trends
Cell Biol. 29:212–226. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Bukowski K, Kciuk M and Kontek R:
Mechanisms of multidrug resistance in cancer chemotherapy. Int J
Mol Sci. 21:32332020. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Baskar R, Lee KA, Yeo R and Yeoh KW:
Cancer and radiation therapy: Current advances and future
directions. Int J Med Sci. 9:193–199. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Mishra S, Yadav T and Rani V: Exploring
miRNA based approaches in cancer diagnostics and therapeutics. Crit
Rev Oncol Hematol. 98:12–23. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Jiang N, Zou C, Zhu Y, Luo Y, Chen L, Lei
Y, Tang K, Sun Y, Zhang W, Li S, et al: HIF-1α-regulated miR-1275
maintains stem cell-like phenotypes and promotes the progression of
LUAD by simultaneously activating Wnt/β-catenin and Notch
signaling. Theranostics. 10:2553–2570. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Du X, Wang S, Liu X, He T, Lin X, Wu S,
Wang D, Li J, Huang W and Yang H: MiR-1307-5p targeting TRAF3
upregulates the MAPK/NF-κB pathway and promotes lung adenocarcinoma
proliferation. Cancer Cell Int. 20:5022020. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
He T, Shen H, Wang S, Wang Y, He Z, Zhu L,
Du X, Wang D, Li J, Zhong S, et al: MicroRNA-3613-5p promotes lung
adenocarcinoma cell proliferation through a RELA and AKT/MAPK
positive feedback loop. Mol Ther Nucleic Acids. 22:572–583. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Ma DB, Qin MM, Shi L and Ding XM:
MicroRNA-6077 enhances the sensitivity of patients-derived lung
adenocarcinoma cells to anlotinib by repressing the activation of
glucose transporter 1 pathway. Cell Signal. 64:1093912019.
View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Song M and Xing X: miR-6742-5p regulates
the invasion and migration of lung adenocarcinoma cells via
mediating FGF8/ERK12/MMP9/MMP2 signaling pathway. Aging (Albany
NY). 15:53–69. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Fang H, Wu W and Wu Z: miR-382-3p
downregulation contributes to the carcinogenesis of lung
adenocarcinoma by promoting AKT SUMOylation and phosphorylation.
Exp Ther Med. 24:4402022. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Lin Q: MicroRNA-1-3p affects lung
adenocarcinoma progression through E2F8 and regulating NF-кB
pathway. Cytokine. 156:1559222022. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Sun Y, Liu W, Zhao Q, Zhang R, Wang J, Pan
P, Shang H, Liu C and Wang C: Down-regulating the expression of
miRNA-21 inhibits the glucose metabolism of A549/DDP cells and
promotes cell death through the PI3K/AKT/mTOR/HIF-1α pathway. Front
Oncol. 11:6535962021. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Edmonds MD, Boyd KL, Moyo T, Mitra R,
Duszynski R, Arrate MP, Chen X, Zhao Z, Blackwell TS, Andl T and
Eischen CM: MicroRNA-31 initiates lung tumorigenesis and promotes
mutant KRAS-driven lung cancer. J Clin Invest. 126:349–364. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Qu J, Li M, An J, Zhao B, Zhong W, Gu Q,
Cao L, Yang H and Hu C: MicroRNA-33b inhibits lung adenocarcinoma
cell growth, invasion, and epithelial-mesenchymal transition by
suppressing Wnt/β-catenin/ZEB1 signaling. Int J Oncol.
47:2141–2152. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Zhou Y, Zhang Y, Li Y, Liu L, Li Z, Liu Y
and Xiao Y: MicroRNA-106a-5p promotes the proliferation, autophagy
and migration of lung adenocarcinoma cells by targeting LKB1/AMPK.
Exp Ther Med. 22:14222021. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Fan X, Liang Y, Liu Y, Bai Y, Yang C and
Xu S: The upregulation of TMPRSS4, partly ascribed to the
downregulation of miR-125a-5p, promotes the growth of human lung
adenocarcinoma via the NF-κB signaling pathway. Int J Oncol.
53:148–158. 2018.PubMed/NCBI
|
|
135
|
Ghoshal-Gupta S, Kutiyanawalla A, Lee BR,
Ojha J, Nurani A, Mondal AK, Kolhe R, Rojiani AM and Rojiani MV:
TIMP-1 downregulation modulates miR-125a-5p expression and triggers
the apoptotic pathway. Oncotarget. 9:8941–8956. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Meng H, Li B, Xu W, Ding R, Xu S, Wu Q and
Zhang Y: miR-140-3p enhances the sensitivity of LUAD cells to
antitumor agents by targeting the ADAM10/Notch pathway. J Cancer.
13:3660–3673. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Jiang WS, Huang CL, Zhang J, Xu F and Dai
XH: MicroRNA-149 inhibits the progression of lung adenocarcinoma
through targeting RAP1B and inactivating Wnt/β-catenin pathway. Eur
Rev Med Pharmacol Sci. 24:4846–4854. 2020.PubMed/NCBI
|
|
138
|
Liu J, Xing Y and Rong L: miR-181
regulates cisplatin-resistant non-small cell lung cancer via
downregulation of autophagy through the PTEN/PI3K/AKT pathway.
Oncol Rep. 39:1631–1639. 2018.PubMed/NCBI
|
|
139
|
Seidl C, Panzitt K, Bertsch A, Brcic L,
Schein S, Mack M, Leithner K, Prinz F, Olschewski H, Kornmueller K
and Hrzenjak A: MicroRNA-182-5p regulates hedgehog signaling
pathway and chemosensitivity of cisplatin-resistant lung
adenocarcinoma cells via targeting GLI2. Cancer Lett. 469:266–276.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Guo L, Wang J, Yang P, Lu Q, Zhang T and
Yang Y: MicroRNA-200 promotes lung cancer cell growth through
FOG2-independent AKT activation. IUBMB Life. 67:720–725. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Liu X, Gao X, Zhang W, Zhu T, Bi W and
Zhang Y: MicroRNA-204 deregulation in lung adenocarcinoma controls
the biological behaviors of endothelial cells potentially by
modulating Janus kinase 2-signal transducer and activator of
transcription 3 pathway. IUBMB Life. 70:81–91. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Watt K, Newsted D, Voorand E, Gooding RJ,
Majewski A, Truesdell P, Yao B, Tuschl T, Renwick N and Craig AW:
MicroRNA-206 suppresses TGF-β signalling to limit tumor growth and
metastasis in lung adenocarcinoma. Cell Signal. 50:25–36. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Lv Q, Hu JX, Li YJ, Xie N, Song DD, Zhao
W, Yan YF, Li BS, Wang PY and Xie SY: MiR-320a effectively
suppresses lung adenocarcinoma cell proliferation and metastasis by
regulating STAT3 signals. Cancer Biol Ther. 18:142–151. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Zhou QY, Gui SY, Zhang P and Wang M:
Upregulation of miR-345-5p suppresses cell growth of lung
adenocarcinoma by regulating ras homolog family member A (RhoA) and
Rho/Rho associated protein kinase (Rho/ROCK) pathway. Chin Med J
(Engl). 134:2619–2628. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Wang Y, Chen T, Huang H, Jiang Y, Yang L,
Lin Z, He H, Liu T, Wu B, Chen J, et al: miR-363-3p inhibits tumor
growth by targeting PCNA in lung adenocarcinoma. Oncotarget.
8:20133–20144. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Wang Y, Zhang S, Bao H, Mu S, Zhang B, Ma
H and Ma S: MicroRNA-365 promotes lung carcinogenesis by
downregulating the USP33/SLIT2/ROBO1 signalling pathway. Cancer
Cell Int. 18:642018. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Xuan YW, Liao M, Zhai WL, Peng LJ and Tang
Y: MicroRNA-381 inhibits lung adenocarcinoma cell biological
progression by directly targeting LMO3 through regulation of the
PI3K/Akt signaling pathway and epithelial-to-mesenchymal
transition. Eur Rev Med Pharmacol Sci. 23:8411–8421.
2019.PubMed/NCBI
|
|
148
|
He B, Wu C, Sun W, Qiu Y, Li J, Liu Z,
Jing T, Wang H and Liao Y: miR-383 increases the cisplatin
sensitivity of lung adenocarcinoma cells through inhibition of the
RBM24-mediated NF-κB signaling pathway. Int J Oncol. 59:872021.
View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Wan L, Zhu L, Xu J, Lu B, Yang Y, Liu F
and Wang Z: MicroRNA-409-3p functions as a tumor suppressor in
human lung adenocarcinoma by targeting c-Met. Cell Physiol Biochem.
34:1273–1290. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Ma J, Huang W, Zhu C, Sun X, Zhang Q,
Zhang L, Qi Q, Bai X, Feng Y and Wang C: miR-423-3p activates FAK
signaling pathway to drive EMT process and tumor growth in lung
adenocarcinoma through targeting CYBRD1. J Clin Lab Anal.
35:e240442021. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Liu R, Wang F, Guo Y, Yang J, Chen S, Gao
X and Wang X: MicroRNA-425 promotes the development of lung
adenocarcinoma via targeting A disintegrin and metalloproteinases 9
(ADAM9). Onco Targets Ther. 11:4065–4073. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Chen D, Huang J, Zhang K, Pan B, Chen J,
De W, Wang R and Chen L: MicroRNA-451 induces
epithelial-mesenchymal transition in docetaxel-resistant lung
adenocarcinoma cells by targeting proto-oncogene c-Myc. Eur J
Cancer. 50:3050–3067. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Li Z, Jiang D and Yang S: MiR-490-3p
inhibits the malignant progression of lung adenocarcinoma. Cancer
Manag Res. 12:10975–10984. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Duan J, Wang L, Shang L, Yang S, Wu H,
Huang Y and Miao Y: miR-152/TNS1 axis inhibits non-small cell lung
cancer progression through Akt/mTOR/RhoA pathway. Biosci Rep.
41:BSR202015392021. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Zhijun Z and Jingkang H: MicroRNA-520e
suppresses non-small-cell lung cancer cell growth by targeting
Zbtb7a-mediated Wnt signaling pathway. Biochem Biophys Res Commun.
486:49–56. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Jiang Z, Zhang J, Chen F and Sun Y:
MiR-148b suppressed non-small cell lung cancer progression via
inhibiting ALCAM through the NF-κB signaling pathway. Thorac
Cancer. 11:415–425. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Jiang W, Wei K, Pan C, Li H, Cao J, Han X,
Tang Y, Zhu S, Yuan W, He Y, et al: MicroRNA-1258 suppresses tumour
progression via GRB2/Ras/Erk pathway in non-small-cell lung cancer.
Cell Prolif. 51:e125022018. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Wu T, Hu H, Zhang T, Jiang L, Li X, Liu S,
Zheng C, Yan G, Chen W, Ning Y, et al: miR-25 promotes cell
proliferation, migration, and invasion of non-small-cell lung
cancer by targeting the LATS2/YAP signaling pathway. Oxid Med Cell
Longev. 2019:97197232019. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Ding X, Zhong T, Jiang L, Huang J, Xia Y
and Hu R: miR-25 enhances cell migration and invasion in
non-small-cell lung cancer cells via ERK signaling pathway by
inhibiting KLF4. Mol Med Rep. 17:7005–7016. 2018.PubMed/NCBI
|
|
160
|
Hu Z, Xiao D, Qiu T, Li J and Liu Z:
MicroRNA-103a curtails the stemness of non-small cell lung cancer
cells by binding OTUB1 via the hippo signaling pathway. Technol
Cancer Res Treat. 19:15330338209716432020. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Jiang K, Shen M, Chen Y and Xu W: miR-150
promotes the proliferation and migration of non-small cell lung
cancer cells by regulating the SIRT2/JMJD2A signaling pathway.
Oncol Rep. 40:943–951. 2018.PubMed/NCBI
|
|
162
|
Xu G, Cai J, Wang L, Jiang L, Huang J, Hu
R and Ding F: MicroRNA-30e-5p suppresses non-small cell lung cancer
tumorigenesis by regulating USP22-mediated Sirt1/JAK/STAT3
signaling. Exp Cell Res. 362:268–278. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Zhang JX, Zhai JF, Yang XT and Wang J:
MicroRNA-132 inhibits migration, invasion and
epithelial-mesenchymal transition by regulating TGFβ1/Smad2 in
human non-small cell lung cancer. Eur Rev Med Pharmacol Sci.
20:3793–3801. 2016.PubMed/NCBI
|
|
164
|
Revathidevi S and Munirajan AK: Akt in
cancer: Mediator and more. Semin Cancer Biol. 59:80–91. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Ward SG, Westwick J and Harris S: Sat-Nav
for T cells: Role of PI3K isoforms and lipid phosphatases in
migration of T lymphocytes. Immunol Lett. 138:15–18. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Altomare DA and Testa JR: Perturbations of
the AKT signaling pathway in human cancer. Oncogene. 24:7455–7464.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Akbarzadeh M, Mihanfar A, Akbarzadeh S,
Yousefi B and Majidinia M: Crosstalk between miRNA and
PI3K/AKT/mTOR signaling pathway in cancer. Life Sci.
285:1199842021. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Zou S, Tong Q, Liu B, Huang W, Tian Y and
Fu X: Targeting STAT3 in Cancer Immunotherapy. Mol Cancer.
19:1452020. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Johnson DE, O'Keefe RA and Grandis JR:
Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev
Clin Oncol. 15:234–248. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Zhan T, Rindtorff N and Boutros M: Wnt
signaling in cancer. Oncogene. 36:1461–1473. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Takebe N, Miele L, Harris PJ, Jeong W,
Bando H, Kahn M, Yang SX and Ivy SP: Targeting Notch, Hedgehog, and
Wnt pathways in cancer stem cells: Clinical update. Nat Rev Clin
Oncol. 12:445–464. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Huang S: mTOR signaling in metabolism and
cancer. Cells. 9:22782020. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Hua H, Kong Q, Zhang H, Wang J, Luo T and
Jiang Y: Targeting mTOR for cancer therapy. J Hematol Oncol.
12:712019. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Kryczka J, Kryczka J, Czarnecka-Chrebelska
KH and Brzeziańska-Lasota E: Molecular mechanisms of
chemoresistance induced by cisplatin in NSCLC cancer therapy. Int J
Mol Sci. 22:88852021. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Dolcet X, Llobet D, Pallares J and
Matias-Guiu X: NF-kB in development and progression of human
cancer. Virchows Arch. 446:475–482. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Bonizzi G and Karin M: The two NF-kappaB
activation pathways and their role in innate and adaptive immunity.
Trends Immunol. 25:280–288. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Lee S, Rauch J and Kolch W: Targeting MAPK
signaling in cancer: Mechanisms of drug resistance and sensitivity.
Int J Mol Sci. 21:11022020. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Asl ER, Amini M, Najafi S, Mansoori B,
Mokhtarzadeh A, Mohammadi A, Lotfinejad P, Bagheri M, Shirjang S,
Lotfi Z, et al: Interplay between MAPK/ERK signaling pathway and
MicroRNAs: A crucial mechanism regulating cancer cell metabolism
and tumor progression. Life Sci. 278:1194992021. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Qi X, Zhang DH, Wu N, Xiao JH, Wang X and
Ma W: ceRNA in cancer: Possible functions and clinical
implications. J Med Genet. 52:710–718. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Arancio W, Pizzolanti G, Genovese SI,
Baiamonte C and Giordano C: Competing endogenous RNA and
interactome bioinformatic analyses on human telomerase.
Rejuvenation Res. 17:161–167. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Yang S, Liu T, Sun Y and Liang X: The long
noncoding RNA LINC00483 promotes lung adenocarcinoma progression by
sponging miR-204-3p. Cell Mol Biol Lett. 24:702019. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Qian Y, Zhang Y, Ji H, Shen Y, Zheng L,
Cheng S and Lu X: LINC01089 suppresses lung adenocarcinoma cell
proliferation and migration via miR-301b-3p/STARD13 axis. BMC Pulm
Med. 21:2422021. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Cai Y, Sheng Z, Chen Y and Wang J: LncRNA
HMMR-AS1 promotes proliferation and metastasis of lung
adenocarcinoma by regulating MiR-138/sirt6 axis. Aging (Albany NY).
11:3041–3054. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Chen W, Li X, Du B, Cui Y, Ma Y and Li Y:
The long noncoding RNA HOXA11-AS promotes lung adenocarcinoma
proliferation and glycolysis via the microRNA-148b-3p/PKM2 axis.
Cancer Med. 12:4421–4433. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Chen X, Chen H, Liu M, Xiong J and Song Z:
Long noncoding RNA LINC00520 accelerates lung adenocarcinoma
progression via miR-1252-5p/FOXR2 pathway. Hum Cell. 34:478–490.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Zhang Y, Li W, Lin Z, Hu J, Wang J, Ren Y,
Wei B, Fan Y and Yang Y: The long noncoding RNA Linc01833 enhances
lung adenocarcinoma progression via MiR-519e-3p/S100A4 axis. Cancer
Manag Res. 12:11157–11167. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Dong HX, Wang R, Jin XY, Zeng J and Pan J:
LncRNA DGCR5 promotes lung adenocarcinoma (LUAD) progression via
inhibiting hsa-mir-22-3p. J Cell Physiol. 233:4126–4136. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Bai J, Li H, Chen X, Chen L, Hu Y, Liu L,
Zhao Y, Zuo W, Zhang B and Yin C: LncRNA-AC009948.5 promotes
invasion and metastasis of lung adenocarcinoma by binding to
miR-186-5p. Front Oncol. 12:9499512022. View Article : Google Scholar : PubMed/NCBI
|
|
189
|
Huang J, Yu Q, Zhou Y, Chu Y, Jiang F and
Wang Q: FAM201A knockdown inhibits proliferation and invasion of
lung adenocarcinoma cells by regulating miR-7515/GLO1 axis. J Cell
Physiol. 236:5620–5632. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Ge Z, Liu H, Ji T, Liu Q, Zhang L, Zhu P,
Li L and Zhu L: Long non-coding RNA 00960 promoted the
aggressiveness of lung adenocarcinoma via the miR-124a/SphK1 axis.
Bioengineered. 13:1276–1287. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Tai G, Fu H, Bai H, Liu H, Li L and Song
T: Long non-coding RNA GLIDR accelerates the tumorigenesis of lung
adenocarcinoma by miR-1270/TCF12 axis. Cell Cycle. 20:1653–1662.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
192
|
Mu X, Wu H, Liu J, Hu X, Wu H, Chen L, Liu
W, Luo S and Zhao Y: Long noncoding RNA TMPO-AS1 promotes lung
adenocarcinoma progression and is negatively regulated by
miR-383-5p. Biomed Pharmacother. 125:1099892020. View Article : Google Scholar : PubMed/NCBI
|
|
193
|
Liu T, Yang C, Wang W and Liu C: LncRNA
SGMS1-AS1 regulates lung adenocarcinoma cell proliferation,
migration, invasion, and EMT progression via miR-106a-5p/MYLI9
axis. Thorac Cancer. 12:2104–2112. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
194
|
Xu Q, Xu Z, Zhu K, Lin J and Ye B:
LINC00346 sponges miR-30c-2-3p to promote the development of lung
adenocarcinoma by targeting MYBL2 and regulating CELL CYCLE
signaling pathway. Front Oncol. 11:6872082021. View Article : Google Scholar : PubMed/NCBI
|
|
195
|
Yao Y, Hua Q and Zhou Y: CircRNA
has_circ_0006427 suppresses the progression of lung adenocarcinoma
by regulating miR-6783-3p/DKK1 axis and inactivating Wnt/β-catenin
signaling pathway. Biochem Biophys Res Commun. 508:37–45. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
196
|
Du J, Zhang G, Qiu H, Yu H and Yuan W: The
novel circular RNA circ-CAMK2A enhances lung adenocarcinoma
metastasis by regulating the miR-615-5p/fibronectin 1 pathway. Cell
Mol Biol Lett. 24:722019. View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Li X, Su S, Ye D, Yu Z, Lu W and Liu L:
Hsa_circ_0020850 promotes the malignant behaviors of lung
adenocarcinoma by regulating miR-326/BECN1 axis. World J Surg
Oncol. 20:132022. View Article : Google Scholar : PubMed/NCBI
|
|
198
|
Ma D, Liu H, Qin Y, Li D, Cui Y, Li L, He
J, Chen Y and Zhou X: Circ_0007142/miR-186/FOXK1 axis promoted lung
adenocarcinoma progression. Am J Transl Res. 12:4728–4738.
2020.PubMed/NCBI
|
|
199
|
Huang C, Yue W, Li L, Li S, Gao C, Si L,
Qi L, Cheng C, Lu M, Chen G, et al: Circular RNA hsa-circ-000881
suppresses the progression of lung adenocarcinoma in vitro via a
miR-665/PRICKLE2 axis. Ann Transl Med. 9:4982021. View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Shi Q and Ju JG: Circ_0001998 regulates
the proliferation, invasion, and apoptosis of lung adenocarcinoma
via sponging miR-145. Evid Based Complement Alternat Med.
2022:64461502022.PubMed/NCBI
|
|
201
|
Fan J, Xia X and Fan Z: Hsa_circ_0129047
regulates the miR-375/ACVRL1 axis to attenuate the progression of
lung adenocarcinoma. J Clin Lab Anal. 36:e245912022. View Article : Google Scholar : PubMed/NCBI
|
|
202
|
Zhang B, Chen M, Jiang N, Shi K and Qian
R: A regulatory circuit of circ-MTO1/miR-17/QKI-5 inhibits the
proliferation of lung adenocarcinoma. Cancer Biol Ther.
20:1127–1135. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
203
|
Wei W, Wang C, Wang L and Zhang J:
circ_0020123 promotes cell proliferation and migration in lung
adenocarcinoma via PDZD8. Open Med (Wars). 17:536–549. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
204
|
Sun Z: Circular RNA hsa_circ_0001588
promotes the malignant progression of lung adenocarcinoma by
modulating miR-524-3p/NACC1 signaling. Life Sci. 259:1181572020.
View Article : Google Scholar : PubMed/NCBI
|
|
205
|
Cao F, Liu S, Li Z, Meng L, Sang M and
Shan B: Activation of circ_0072088/miR-1261/PIK3CA pathway
accelerates lung adenocarcinoma progression. Thorac Cancer.
13:1548–1557. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
206
|
Panda AC: Circular RNAs Act as miRNA
sponges. Adv Exp Med Biol. 1087:67–79. 2018. View Article : Google Scholar : PubMed/NCBI
|
